Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-039162
Filing Date
2013-07-08
Accepted
2013-07-08 16:15:55
Documents
1
Period of Report
2013-07-03

Document Format Files

Seq Description Document Type Size
1 rrd384923.html 3  
1 rrd384923.xml 3 2102
  Complete submission text file 0001181431-13-039162.txt   3553
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MORRIS COMMUNICATIONS CORP 725 BROAD ST. AUGUSTA GA 30903
Business Address
RICCIARDI NATALE S (Reporting) CIK: 0001107158 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 13957650